Indolocarbazoles: potent, selective inhibitors of human cytomegalovirus replication. 1999

M J Slater, and S Cockerill, and R Baxter, and R W Bonser, and K Gohil, and C Gowrie, and J E Robinson, and E Littler, and N Parry, and R Randall, and W Snowden
GlaxoWellcome Medicines Research Centre, Stevenage, UK. MJS40312@glaxowellcome.co.uk

In our search for new, safer anti-HCMV agents, we discovered that the natural product Arcyriaflavin A (la) was a potent inhibitor of HCMV replication in cell culture. A series of analogues (symmetrical indolocarbazoles) was synthesised to investigate structure activity relationships in this series against a range of herpes viruses (HCMV, VZV, HSV1, and 2). This identified a number of novel, selective and potent inhibitors of HCMV, 12,13-dihydro-2,10-difluoro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol e-5,7-(6H)-dione (1d) being the best example (IC50=40 nM, therapeutic index > 1450). Compounds described in this series were generally poor inhibitors of protein kinase C betaII, and no correlation was found between the ability to inhibit HCMV and the enzyme PKC.

UI MeSH Term Description Entries
D011493 Protein Kinase C An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters. Calcium Phospholipid-Dependent Protein Kinase,Calcium-Activated Phospholipid-Dependent Kinase,PKC Serine-Threonine Kinase,Phospholipid-Sensitive Calcium-Dependent Protein Kinase,Protein Kinase M,Calcium Activated Phospholipid Dependent Kinase,Calcium Phospholipid Dependent Protein Kinase,PKC Serine Threonine Kinase,Phospholipid Sensitive Calcium Dependent Protein Kinase,Phospholipid-Dependent Kinase, Calcium-Activated,Serine-Threonine Kinase, PKC
D002227 Carbazoles Benzo-indoles similar to CARBOLINES which are pyrido-indoles. In plants, carbazoles are derived from indole and form some of the INDOLE ALKALOIDS.
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002522 Chlorocebus aethiops A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research. African Green Monkey,Cercopithecus aethiops,Cercopithecus griseoviridis,Cercopithecus griseus,Cercopithecus pygerythrus,Cercopithecus sabeus,Cercopithecus tantalus,Chlorocebus cynosuros,Chlorocebus cynosurus,Chlorocebus pygerythrus,Green Monkey,Grivet Monkey,Lasiopyga weidholzi,Malbrouck,Malbrouck Monkey,Monkey, African Green,Monkey, Green,Monkey, Grivet,Monkey, Vervet,Savanah Monkey,Vervet Monkey,Savannah Monkey,African Green Monkey,Chlorocebus cynosuro,Green Monkey, African,Green Monkeys,Grivet Monkeys,Malbrouck Monkeys,Malbroucks,Monkey, Malbrouck,Monkey, Savanah,Monkey, Savannah,Savannah Monkeys,Vervet Monkeys
D003587 Cytomegalovirus A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS. Herpesvirus 5, Human,Human Herpesvirus 5,Salivary Gland Viruses,HHV 5,Herpesvirus 5 (beta), Human,Cytomegaloviruses,Salivary Gland Virus,Virus, Salivary Gland,Viruses, Salivary Gland
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006564 Herpesviridae A family of enveloped, linear, double-stranded DNA viruses infecting a wide variety of animals. Subfamilies, based on biological characteristics, include: ALPHAHERPESVIRINAE; BETAHERPESVIRINAE; and GAMMAHERPESVIRINAE. Mouse Thymic Virus,Murid herpesvirus 3,Thymic Group Viruses,Herpesviruses,Mouse Thymic Viruses,Thymic Virus, Mouse,Thymic Viruses, Mouse
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

M J Slater, and S Cockerill, and R Baxter, and R W Bonser, and K Gohil, and C Gowrie, and J E Robinson, and E Littler, and N Parry, and R Randall, and W Snowden
February 1998, Biochemical pharmacology,
M J Slater, and S Cockerill, and R Baxter, and R W Bonser, and K Gohil, and C Gowrie, and J E Robinson, and E Littler, and N Parry, and R Randall, and W Snowden
October 2000, Antiviral research,
M J Slater, and S Cockerill, and R Baxter, and R W Bonser, and K Gohil, and C Gowrie, and J E Robinson, and E Littler, and N Parry, and R Randall, and W Snowden
July 2009, Chemical communications (Cambridge, England),
M J Slater, and S Cockerill, and R Baxter, and R W Bonser, and K Gohil, and C Gowrie, and J E Robinson, and E Littler, and N Parry, and R Randall, and W Snowden
September 1999, Bioorganic & medicinal chemistry letters,
M J Slater, and S Cockerill, and R Baxter, and R W Bonser, and K Gohil, and C Gowrie, and J E Robinson, and E Littler, and N Parry, and R Randall, and W Snowden
November 2012, Anti-cancer agents in medicinal chemistry,
M J Slater, and S Cockerill, and R Baxter, and R W Bonser, and K Gohil, and C Gowrie, and J E Robinson, and E Littler, and N Parry, and R Randall, and W Snowden
August 2002, Antimicrobial agents and chemotherapy,
M J Slater, and S Cockerill, and R Baxter, and R W Bonser, and K Gohil, and C Gowrie, and J E Robinson, and E Littler, and N Parry, and R Randall, and W Snowden
September 1998, Antiviral chemistry & chemotherapy,
M J Slater, and S Cockerill, and R Baxter, and R W Bonser, and K Gohil, and C Gowrie, and J E Robinson, and E Littler, and N Parry, and R Randall, and W Snowden
June 1982, Nature,
M J Slater, and S Cockerill, and R Baxter, and R W Bonser, and K Gohil, and C Gowrie, and J E Robinson, and E Littler, and N Parry, and R Randall, and W Snowden
December 1988, Antimicrobial agents and chemotherapy,
M J Slater, and S Cockerill, and R Baxter, and R W Bonser, and K Gohil, and C Gowrie, and J E Robinson, and E Littler, and N Parry, and R Randall, and W Snowden
August 1999, Journal of medicinal chemistry,
Copied contents to your clipboard!